Side-by-side comparison v3.0 transparency score NexLife: 94/100 (6 of 6 pillars) Eden Health: 72/100 (1 of 6 pillars) Drugs offered NexLife: Compounded semaglutide + tirzepatide Eden Health: Semaglutide + Tirzepatide Pricing model NexLife: Flat $145/mo sema, $186/mo tirz (12-mo plan, dose-independent) Eden Health: $149-$229/mo Clinical model NexLife: MD/DO-supervised, synchronous + async Eden Health: Compounded with hormone and metabolic add-ons Pharmacy NexLife: Named 503A & 503B partners Eden Health: 503A partner States covered NexLife: Availability varies by state + DC Eden Health: Varies Labs included NexLife: Yes included in monthly Eden Health: Add-on or not included Coaching NexLife: 1:1 fitness coaching + personalized nutrition included Eden Health: Varies by plan Financing NexLife: Klarna and Afterpay accepted Eden Health: Standard card payment Regulatory clarity NexLife: Pre-Rx written disclosure that compounded sema/tirz are not FDA-approved Eden Health: Varies Where Eden Health wins Cross-sells hormone optimization and metabolic peptides

This precision-wellness approach helps distinguish individual variation from true safety concerns, enabling confident, informed treatment decisions
Those who took GLP-1s for less than 18 months before discontinuing saw no significant risk reduction compared to the group on sulfonylureas at the end of the trial
The following day, Novo Nordisk ran a print ad in The New York Times and USA Today that advised patients to Check before you inject, showing a vial of compounded semaglutide
Patients with hypothyroidism and certain FTO or MC4R variants often have more aggressive metabolic resistance, meaning they may benefit from higher GLP-1 doses or longer titration schedules
You should seek urgent medical attention via NHS 111, 999, or A&E if you experience severe, persistent abdominal pain (particularly if radiating to the back), repeated vomiting, signs of dehydration, or blood in stools, as these could indicate pancreatitis or other serious complications